Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 5, 2025 • 7:00 PM ET

Date/Time Source News Release
04/03/2025 12:34 PM EDT Business Wire ALDX BREAKING NEWS: BFA Law Announces an Investigation into Aldeyra Therapeutics, Inc. 75% Stock Drop; Investors are Notified to Contact BFA Law
04/03/2025 11:58 AM EDT GlobeNewswire ALDX BREAKING NEWS: Aldeyra Therapeutics, Inc. 75% Stock Drop Triggers Securities Investigation; Contact BFA Law if You Lost Money (NASDAQ:ALDX)
04/03/2025 11:07 AM EDT GlobeNewswire BREAKING: Block & Leviton Investigating Aldeyra Therapeutics (ALDX) For Securities Fraud After Shares Fall Nearly 75%; Investors Encouraged to Contact the Firm
04/03/2025 08:00 AM EDT Business Wire Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
03/10/2025 07:00 AM EDT Business Wire Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference
02/18/2025 02:12 PM EST GlobeNewswire Aldeyra, UnitedHealth Group Incorporated, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
02/05/2025 08:24 AM EST Newsfile Aldeyra Therapeutics, Inc. (ALDX) Notice: Grabar Law Office Is Investigating Claims for Long-Term Shareholders
02/04/2025 07:00 AM EST Business Wire Aldeyra Therapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference
12/26/2024 07:59 PM EST GlobeNewswire Aldeyra, UnitedHealth Group Incorporated, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
12/02/2024 07:00 AM EST Business Wire Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference
Page

Additional News

As of April 5, 2025 • 7:00 PM ET

Date/Time Source News Release
04/05/2025 05:55 PM EDT SeekingAlpha Top 10 Russell 2000 weekly gainers and losers as Wall Street crashes
04/04/2025 10:00 AM EDT ACCESS Newswire IA Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Investors to Reach Out
04/04/2025 07:33 AM EDT ACCESS Newswire IA ALDX NOTIFICATION: Aldeyra Therapeutics, Inc. is being Investigated for Securities Violations after 75% Stock Drop; Investors with Losses are Notified to Contact BFA Law
04/03/2025 05:30 PM EDT ACCESS Newswire IA Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out
04/03/2025 08:42 AM EDT SeekingAlpha Aldeyra tumbles as FDA snubs dry eye disease therapy
03/12/2025 11:24 AM EDT InvestorBrandNetwork Aldeyra Therapeutics Inc. (NASDAQ: ALDX) Records 52-Week High Wednesday Morning
03/05/2025 04:09 PM EST SeekingAlpha Aldeyra Therapeutics Is Severely Undervalued Before PDUFA
03/03/2025 11:06 AM EST InvestorBrandNetwork Aldeyra Therapeutics Inc. (NASDAQ: ALDX) Sees Notable Increase in Monday Morning Market Activity
03/02/2025 04:30 AM EST US Earnings Reports Expected earnings - Aldeyra Therapeutics Inc.
02/24/2025 01:48 AM EST Stock Traders Daily (ALDX) Trading Report
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.